430282850	430282850	CD	B-NP	O
|	|	NN	I-NP	O
BMC	BMC	NN	I-NP	O
|	|	NN	I-NP	O
74886372	74886372	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9005685	9005685	CD	B-NP	O
|	|	CC	I-NP	O
6/24/2005	6/24/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	O
,	,	,	O	O
HYPONATREMIA	HYPONATREMIA	NNP	B-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/16/2005	10/16/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/2005	10/2/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
FLATTERY	FLATTERY	NN	B-NP	O
,	,	,	O	O
SHAD	SHAD	NNP	B-NP	O
SANTO	SANTO	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Decompensated	Decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Transfer	Transfer	NN	B-NP	O
from	from	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
with	with	IN	B-PP	O
ICD/biventricular	ICD/biventricular	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
initially	initially	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Memoff	Memoff	NNP	B-NP	O
Deelaen	Deelaen	NNP	I-NP	O
's	's	POS	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
presyncopal	presyncopal	JJ	B-ADJP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
possibly	possibly	RB	B-NP	O
feeling	feel	VBG	I-NP	O
weak	weak	JJ	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
p.o.	p.o.	FW	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
with	with	IN	B-PP	O
little	little	JJ	B-NP	O
success	success	NN	I-NP	O
in	in	IN	B-PP	O
treating	treat	VBG	B-VP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
sodium	sodium	NN	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
117	117	CD	B-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
withheld	withhold	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restricted	restrict	VBN	I-VP	O
on	on	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
comes	come	VBZ	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
therapy	therapy	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
CVA	CVA	NN	I-NP	B-protein
in	in	IN	B-PP	O
10/5	10/5	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
residual	residual	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
while	while	IN	B-SBAR	O
off	off	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
knows	know	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
some	some	DT	B-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	I-NP	O
difficulty	difficulty	NN	I-NP	O
lying	lie	VBG	B-VP	O
completely	completely	RB	B-ADJP	O
flat	flat	JJ	I-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
biventricular	biventricular	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
and	and	CC	I-NP	O
ICD	ICD	NN	I-NP	B-protein
on	on	IN	B-PP	O
an	an	DT	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CVA	CVA	NN	B-NP	O
in	in	IN	B-PP	O
7/17	7/17	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Neurontin	Neurontin	NN	B-NP	B-protein
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxycodone	oxycodone	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Agoraphobic/anxiety	Agoraphobic/anxiety	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Xanax	Xanax	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
60	60	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Vicodin	Vicodin	NNP	B-NP	O
q.	q.	NNP	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
AT	AT	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
96.6	96.6	CD	I-NP	I-protein
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
98/60	98/60	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
70	70	CD	I-NP	O
.	.	.	O	O

General	General	JJ	B-NP	O
appearance	appearance	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Awake	Awake	NN	B-NP	O
,	,	,	O	O
alert	alert	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
to	to	TO	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
person	person	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
somewhat	somewhat	RB	B-VP	O
oriented	orient	VBN	I-VP	O
to	to	TO	B-PP	O
time	time	NN	B-NP	O
,	,	,	O	O
knows	know	VBZ	B-VP	O
ear	ear	NN	B-NP	O
and	and	CC	I-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
Crackles	Crackle	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
lung	lung	NN	I-NP	O
fields	field	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
3/6	3/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
18	18	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Trace	Trace	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
bilaterally	bilaterally	RB	B-NP	I-protein
1	1	CD	I-NP	I-protein
+	+	SYM	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Remembers	Remember	NNS	B-NP	O
2/3	2/3	CD	B-NP	O
objects	object	NNS	I-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x2-3	x2-3	NN	I-NP	O
,	,	,	O	O
follows	follow	VBZ	B-VP	O
commands	command	NNS	B-NP	O
,	,	,	O	O
slurred	slur	VBD	B-VP	O
speech	speech	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
bit	bit	NN	I-NP	O
drowsy	drowsy	NN	I-NP	O
but	but	CC	O	O
alert	alert	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ptosis	ptosis	NN	I-NP	O
.	.	.	O	O

4/5	4/5	CD	B-NP	O
strength	strength	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
120	120	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
0.9	0.9	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.8	4.8	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
6.9	6.9	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
42.5	42.5	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
2.1	2.1	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
V	V	NN	B-NP	O
paced	pace	VBD	B-VP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
Pleural	Pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65-year-old	65-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
non-ischemic	non-ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
biventricular	biventricular	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
,	,	,	O	O
ICD	ICD	NN	B-NP	B-protein
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
from	from	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
and	and	CC	O	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
significant	significant	JJ	B-NP	O
decompensated	decompensate	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
IV	IV	CD	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
-1	-1	CD	B-NP	O
to	to	TO	I-NP	O
-2	-2	CD	I-NP	O
liters	liter	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Daily	Daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
strict	strict	NN	B-NP	O
I	I	CD	I-NP	O
&	&	CC	I-NP	O
Os	O	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
free	free	JJ	I-NP	O
water	water	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
thiazides	thiazide	NNS	B-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
gradually	gradually	RB	I-ADVP	O
back	back	RB	B-ADVP	O
up	up	RB	I-ADVP	O
in	in	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	B-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
well	well	RB	B-ADVP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
83.5	83.5	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
273	273	CD	I-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
much	much	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
energy	energy	NN	B-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Subjectively	Subjectively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
felt	feel	VBD	B-VP	O
better	well	RBR	B-ADVP	O
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
slowly	slowly	RB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
CHF	CHF	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Zestril	Zestril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
added	add	VBN	I-VP	O
,	,	,	O	O
specifically	specifically	RB	B-NP	O
Coreg	Coreg	NN	I-NP	O
at	at	IN	B-PP	O
3.125	3.125	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.o.	p.o.	FW	I-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	O	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
point	point	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Lasix	Lasix	NN	B-NP	O
drip	drip	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
responding	respond	VBG	I-VP	O
to	to	TO	B-PP	O
diuretics	diuretic	NNS	B-NP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
Echocardiogram	Echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
reversal	reversal	NN	B-NP	O
of	of	IN	B-PP	O
flow	flow	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
venous	venous	JJ	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
consideration	consideration	NN	B-NP	O
and	and	CC	I-NP	O
discussion	discussion	NN	I-NP	O
about	about	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
amenable	amenable	JJ	B-ADJP	O
to	to	TO	B-VP	O
procedure	procedure	VB	I-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mcgrue	Mcgrue	NNP	I-NP	O
This	This	NNP	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O
and	and	CC	I-VP	O
coordinated	coordinate	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
and	and	CC	O	O
him	him	PRP	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
percutaneous	percutaneous	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
possibly	possibly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
actively	actively	RB	I-VP	O
being	be	VBG	I-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
B.	B.	NNP	I-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ICD	ICD	NN	I-NP	O
and	and	CC	O	O
biventricular	biventricular	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
towards	towards	IN	B-PP	O
end	end	NN	B-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
replacement	replacement	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
not	not	RB	O	O
urgent	urgent	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
ICD/biventricular	ICD/biventricular	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Neuse	Neuse	NNP	I-NP	O
on	on	IN	B-PP	O
4/20/05	4/20/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ICD	ICD	NN	I-NP	O
pocket	pocket	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
pocket	pocket	NN	B-NP	O
hematoma	hematoma	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
and	and	CC	I-NP	O
new	new	JJ	I-NP	O
ICD/pacer	ICD/pacer	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
functioning	function	VBG	I-VP	O
properly	properly	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
bleeding	bleeding	NN	B-NP	O
or	or	CC	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

EKGs	EKG	NNS	B-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
only	only	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
after	after	IN	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

Fingersticks	Fingerstick	NNS	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
good	good	JJ	B-NP	O
sugar	sugar	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Fingersticks	Fingerstick	NNS	B-NP	O
were	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
mostly	mostly	RB	B-ADVP	O
between	between	IN	B-PP	O
100	100	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
120	120	CD	I-NP	I-DNA
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
checked	check	VBN	I-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
electrolytes	electrolyte	NNS	B-NP	O
and	and	CC	O	O
repleted	replete	VBN	B-VP	O
for	for	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
thiazides	thiazide	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
as	as	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
slightly	slightly	RB	I-VP	O
modified	modify	VBN	I-VP	O
eventually	eventually	RB	B-ADVP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
2	2	CD	I-NP	O
to	to	TO	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

ICD	ICD	NN	B-NP	O
replacement	replacement	NN	I-NP	O
procedure	procedure	NN	I-NP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bjella	Bjella	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
foal	foal	JJ	I-NP	O
INR	INR	NN	I-NP	O
between	between	IN	B-PP	O
2.0	2.0	CD	B-NP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Psyche/Neuro	Psyche/Neuro	NNP	B-NP	O
:	:	:	O	O
Continued	Continue	VBN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Xanax	Xanax	NN	B-NP	O
,	,	,	I-NP	O
Neurontin	Neurontin	NN	I-NP	B-protein
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
medication	medication	NN	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
GI	GI	NN	B-NP	B-protein
prophylaxis	prophylaxis	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
regular	regular	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
sessions	session	NNS	I-NP	O
inhouse	inhouse	VBP	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
functional	functional	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
UA	UA	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
possible	possible	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
contributed	contribute	VBN	I-VP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
decompensated	decompensate	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
initial	initial	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
feeling	feeling	NN	B-NP	O
weak	weak	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
citrobacter	citrobacter	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
isolation	isolation	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
strain	strain	NN	I-NP	O
was	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
contact	contact	NN	B-NP	O
isolation	isolation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
fevers	fever	NNS	B-NP	O
throughout	throughout	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
UA	UA	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
adequately	adequately	RB	I-VP	O
treated	treat	VBN	I-VP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Iturbe	Iturbe	NNP	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
follow	follow	VBP	B-VP	O
up	up	IN	B-PRT	O
and	and	CC	O	O
INR	INR	NN	B-NP	O
blood	blood	NN	I-NP	O
draws	draw	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-9365056	4-9365056	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ROSI	ROSI	NNP	B-NP	O
,	,	,	O	O
ALAN	ALAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STROBLE	STROBLE	NNP	B-NP	O
,	,	,	O	O
WAYLON	WAYLON	NNP	B-NP	O
HERIBERTO	HERIBERTO	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2453819	2453819	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/13/05	1/13/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/13/05	1/13/05	CD	B-NP	O

